TGFB1 and diabetic kidney disease: In diabetic kidney disease (DKD), Wang et al. found that chemerin can enhance the TGF-β1/SMAD/CTGF signaling pathway both in vitro and in vivo, thereby promoting the development and progression of DKD and causing a significant reduction in renal function [69].